FDA OKs First Drug for Hyperphagia in Prader-Willi Syndrome

(MedPage Today) — The FDA approved extended-release diazoxide choline (Vykat XR) to treat the intense persistent sensation of hunger in patients 4 years of age and older with Prader-Willi syndrome, maker Soleno Therapeutics announced.
“The FDA…

Source link : https://www.medpagetoday.com/endocrinology/growthdisorders/114856

Author :

Publish date : 2025-03-27 18:35:00

Copyright for syndicated content belongs to the linked Source.

M	T	W	T	F	S	S
			1	2	3	4
5	6	7	8	9	10	11
12	13	14	15	16	17	18
19	20	21	22	23	24	25
26	27	28	29	30	31

FDA OKs First Drug for Hyperphagia in Prader-Willi Syndrome

U.S. Burden of Liver Disease; Active IBD and Pregnancy; All-Cause Mortality in MASLD

Antibiotic-Resistant Gonorrhoea Cases Rise in England

Related Posts

Adult Sugammadex Dosing Safe, Effective in Kids Aged < 2

Helping on the farm in Surrey is reaping mental health rewards

Sedentary Time Tied to Brain Volume, Worse Cognition in Older Adults

Expect More Downside Risk in Medicare’s Payment Models, CMS Official Says

Better Survival in BRCA-Mutated Breast Cancer With Neoadjuvant Olaparib-Chemo Combo

Doctors, Other Healthcare Workers Strike in Washington State

Adult Sugammadex Dosing Safe, Effective in Kids Aged < 2

Helping on the farm in Surrey is reaping mental health rewards

Sedentary Time Tied to Brain Volume, Worse Cognition in Older Adults

Expect More Downside Risk in Medicare’s Payment Models, CMS Official Says

Better Survival in BRCA-Mutated Breast Cancer With Neoadjuvant Olaparib-Chemo Combo

Doctors, Other Healthcare Workers Strike in Washington State

HIV Drugs and Alzheimer’s; Duchenne Drug Shows Benefit; PFAS and Cognitive Changes

Low LDL and Bleeding Risk; Improved HoFH Life Expectancy; ANGPTL4 mAb Progress

Categories

Archives